Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

AWS upgraded its SageMaker platform to offer more observability and streamlined functions to make AI model inference and training easier.

When someone saw real projected lines, activity in the fusiform gyrus was stronger than when they knew they were simply ...

Deals have been flying from every direction this week, but we want to make sure you don’t miss out on everything Walmart has ...

Since its development 100 years ago, quantum mechanics has revolutionized our understanding of nature, revealing a bizarre ...

It's the final day of Amazon Prime Day 2025 and time is running out to shop some of Amazon Canada's lowest prices of the year. Prime Day is a phenomenal opportunity to save on brand-name tech, home ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

Stryker’s stock recently got a promising upgrade from Evercore ISI, which raised its price target significantly. Evercore ISI ...